Gameto is a Biotech company based in New York, NY. It has raised $127M in total funding. Latest round: Series C.
Gameto funding overview
Gameto is a Biotech company based in New York, NY. Gameto has raised $127M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in July 2025. The round record for Gameto runs through 2025; nothing later has been disclosed. Investors on record include Overwater Ventures, Two Sigma Ventures, RA Capital, Future Ventures, Insight Partners, Bold Capital and 4 others. 10 distinct backers are named across the disclosed rounds.
Gameto at a glance
Total raised
$127M
Latest round
Series C
Latest round date
July 2025
Industry
Biotech
Headquarters
New York, NY
Notable investors
Overwater Ventures, Two Sigma Ventures, RA Capital, Future Ventures, Insight Partners, Bold Capital, Lux Capital, Ingeborg Investments
Frequently asked about Gameto funding
How much has Gameto raised?
Gameto has raised $127M in total disclosed funding across the rounds on record.
Who has invested in Gameto?
Overwater Ventures, Two Sigma Ventures, RA Capital, Future Ventures, Insight Partners, Bold Capital are named among the investors backing Gameto.
What was the latest Gameto funding round?
The most recent disclosed round is a Series C, announced in July 2025.
Where is Gameto based?
Gameto is based in New York, NY.
What sector does Gameto operate in?
Gameto is tracked under Biotech from New York, NY, with $127M in disclosed funding.
When did Gameto last raise?
The last disclosed Gameto round closed in July 2025 at Series C.
Totals shown for Gameto aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in New York and the investors behind them below.
